2018•International Journal of Clinical PharmacyRequires access

Optimal timing for pegfilgrastim administration in Japanese breast cancer patients receiving intermediate-risk chemotherapies

Tatsuya Hayama, Kenichi Sakurai, Katsuhiro Miura, Shinsaku Washinosu, Shinya Tsuboi, Akihiro Uchiike, Yoshikazu Yoshida, Masami Takei

Open publisher page 4 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Pegfilgrastim, Medicine, Breast cancer, Internal medicine, Univariate analysis, Oncology, Filgrastim, Odds ratio

Back to paper search Browse research topics Original source

Optimal timing for pegfilgrastim administration in Japanese breast cancer patients receiving intermediate-risk chemotherapies — Research Paper | ScholarLens